Beck Mack & Oliver’s Pfizer PFE Stock Holding History

Beck Mack & Oliver’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.12M	Hold	88,126	–	–	0.04%	92
2026 Q1	$2.47M	Sell	88,126 -500	-0.6%	-$13.3K	0.05%	88
2025 Q4	$2.21M	Buy	88,626 +1	+0%	+$25	0.04%	89
2025 Q3	$2.26M	Hold	88,625	–	–	0.04%	86
2025 Q2	$2.15M	Buy	88,625 +1,119	+1%	+$26.1K	0.04%	84
2025 Q1	$2.22M	Buy	87,506 +1,500	+2%	+$39.3K	0.04%	86
2024 Q4	$2.28M	Hold	86,006	–	–	0.04%	84
2024 Q3	$2.49M	Buy	86,006 +6	+0%	+$175	0.05%	83
2024 Q2	$2.41M	Sell	86,000 -2,000	-2%	-$55.1K	0.05%	83
2024 Q1	$2.44M	Hold	88,000	–	–	0.05%	82
2023 Q4	$2.53M	Sell	88,000 -25	-0%	-$756	0.06%	79
2023 Q3	$2.92M	Sell	88,025 -4,437	-5%	-$157K	0.08%	75
2023 Q2	$3.39M	Hold	92,462	–	–	0.09%	72
2023 Q1	$3.77M	Hold	92,462	–	–	0.11%	70
2022 Q4	$4.74M	Hold	92,462	–	–	0.14%	67
2022 Q3	$4.05M	Sell	92,462 -46	-0%	-$2.23K	0.13%	70
2022 Q2	$4.85M	Buy	92,508 +46	+0%	+$2.34K	0.15%	66
2022 Q1	$4.79M	Hold	92,462	–	–	0.12%	73
2021 Q4	$5.46M	Hold	92,462	–	–	0.13%	64
2021 Q3	$3.98M	Sell	92,462 -76	-0.1%	-$3.37K	0.1%	68
2021 Q2	$3.62M	Buy	92,538 +76	+0.1%	+$2.96K	0.1%	69
2021 Q1	$3.35M	Sell	92,462 -800	-0.9%	-$28.4K	0.1%	72
2020 Q4	$3.43M	Sell	93,262 -5,106	-5%	-$187K	0.11%	72
2020 Q3	$3.42M	Hold	98,368	–	–	0.13%	69
2020 Q2	$3.05M	Hold	98,368	–	–	0.11%	71
2020 Q1	$3.05M	Hold	98,368	–	–	0.14%	66
2019 Q4	$3.66M	Hold	98,368	–	–	0.12%	67
2019 Q3	$3.35M	Sell	98,368 -3,478	-3%	-$126K	0.12%	66
2019 Q2	$4.19M	Hold	101,846	–	–	0.15%	65
2019 Q1	$4.1M	Hold	101,846	–	–	0.15%	66
2018 Q4	$4.22M	Hold	101,846	–	–	0.17%	66
2018 Q3	$4.26M	Hold	101,846	–	–	0.14%	69
2018 Q2	$3.51M	Sell	101,846 -42	-0%	-$1.44K	0.12%	74
2018 Q1	$3.43M	Sell	101,888 -1,434	-1%	-$49.3K	0.12%	75
2017 Q4	$3.55M	Hold	103,322	–	–	0.12%	76
2017 Q3	$3.5M	Sell	103,322 -1,054	-1%	-$33.9K	0.12%	78
2017 Q2	$3.33M	Hold	104,376	–	–	0.11%	79
2017 Q1	$3.39M	Hold	104,376	–	–	0.12%	79
2016 Q4	$3.22M	Hold	104,376	–	–	0.12%	77
2016 Q3	$3.35M	Sell	104,376 -2,881	-3%	-$96.3K	0.12%	80
2016 Q2	$3.58M	Hold	107,257	–	–	0.13%	76
2016 Q1	$3.02M	Sell	107,257 -6,800	-6%	-$194K	0.11%	82
2015 Q4	$3.49M	Sell	114,057 -15,764	-12%	-$496K	0.12%	79
2015 Q3	$3.87M	Sell	129,821 -739	-0.6%	-$23.7K	0.12%	80
2015 Q2	$4.15M	Sell	130,560 -3,860	-3%	-$126K	0.11%	83
2015 Q1	$4.44M	Sell	134,420 -3,360	-2%	-$107K	0.11%	81
2014 Q4	$4.07M	Buy	137,780 +1,357	+1%	+$38.9K	0.1%	87
2014 Q3	$3.83M	Buy	136,423 +10	+0%	+$281	0.09%	94
2014 Q2	$3.84M	Buy	136,413 +565	+0.4%	+$16.1K	0.09%	92
2014 Q1	$4.14M	Sell	135,848 -2,632	-2%	-$78.5K	0.1%	86
2013 Q4	$4.02M	Sell	138,480 -1,562	-1%	-$45.5K	0.1%	86
2013 Q3	$3.82M	Sell	140,042 -3,233	-2%	-$88K	0.1%	88
2013 Q2	$3.81M	Buy	+143,275	New	+$3.96M	0.1%	85

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Beck Mack & Oliver's PFE Position: Q2 2026 in Review

Beck Mack & Oliver held its Pfizer (PFE) position steady in Q2 2026 at 88,126 shares worth $2.12M. The position accounts for 0.04% of the portfolio, ranked #92.

Beck Mack & Oliver first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.46M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Beck Mack & Oliver held 88,126 shares of Pfizer worth $2.12M as of Q2 2026.
Beck Mack & Oliver left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.04% of Beck Mack & Oliver's portfolio in Q2 2026, its #92 holding.
Beck Mack & Oliver first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Beck Mack & Oliver's Pfizer position peaked at $5.46M in Q4 2021.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Beck Mack & Oliver's 13F filing for Q2 2026, filed 14 Aug 2026.